Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jessica Suschak"'
Autor:
William E. Pierceall, Michele Wolfe, Jessica Suschak, Hua Chang, Yan Chen, Kam M. Sprott, Jeffery L. Kutok, Stella Quan, David T. Weaver, Brian E. Ward
Publikováno v:
Analytical Cellular Pathology, Vol 34, Iss 3, Pp 159-168 (2011)
Digital quantitative immunohistochemical analysis of protein biomarker expression offers a broad dynamic range against which clinical outcomes may be measured. Semi-quantitative expression data represented as an H-score is produced by computer genera
Externí odkaz:
https://doaj.org/article/c3d2f9acca124062a912c1cd75184915
Autor:
Andrew Chow, Louis L. Gardner, Jacob N. Wohlstadter, Animesh Shukla, Jessica Suschak, Su Wang, Sheldon Grove, Anu Mathew, Martin Stengelin, Anahit Aghvanyan, Thomas W. Miller, Sarah E Wheeler
Publikováno v:
Cancer Research. 77:4030A-4030A
Cardiovascular toxicity is a potential complication of multiple anticancer therapies. Some drugs, such as anthracyclines, have been implicated in irreversible cardiac dysfunction. Cardiac troponin is a specific and sensitive marker of myocardial inju
Autor:
Pankaj Oberoi, Jessica Suschak, Martin Stenglin, Anahit Aghvanyan, Galina Nikolenko, Daisy Roy, Louis Gardner, Dustin Lockney, Animesh Shukla, Erica Porter, Thomas Miller, Adrianna Biesso, Laukik Sardesai, Ramou Sivakamasundar, Anu Mathew, Eli N Glezer, Jacob N Wohlstadter
Publikováno v:
The Journal of Immunology. 196:138.9-138.9
We developed immunoassays with fg/mL detection limits, 100 to 1,000X more sensitive than current ELISA technology. We measured concentrations of low-abundance cytokines and other biomarkers in the serum of healthy donors, and found that these analyte
Autor:
John H. Kenten, Jessica Suschak, Kristian Roth, Bandele Jeffery-Coker, Fei Yin, Eli N. Glezer
Publikováno v:
Cancer Research. 70:3999-3999
Early detection, identification and classification of cancers still present considerable challenges. Innovations in several areas of research have provided novel and powerful approaches with which to tackle these challenges. Autoantibodies to tumor a